C4 Therapeutics, Inc. (CCCC)
3.865
+0.16
(+4.18%)
USD |
NASDAQ |
Sep 01, 16:00
3.865
0.00 (0.00%)
After-Hours: 17:44
C4 Therapeutics Cash from Operations (TTM) : -84.87M for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -84.87M |
| March 31, 2026 | -95.35M |
| December 31, 2025 | -98.69M |
| September 30, 2025 | -94.48M |
| June 30, 2025 | -87.41M |
| March 31, 2025 | -80.32M |
| December 31, 2024 | -65.16M |
| September 30, 2024 | -71.23M |
| June 30, 2024 | -77.81M |
| March 31, 2024 | -91.83M |
| Date | Value |
|---|---|
| December 31, 2023 | -106.84M |
| September 30, 2023 | -111.96M |
| June 30, 2023 | -109.27M |
| March 31, 2023 | -112.47M |
| December 31, 2022 | -105.94M |
| September 30, 2022 | -102.48M |
| June 30, 2022 | -92.82M |
| March 31, 2022 | -88.63M |
| December 31, 2021 | -86.96M |
| September 30, 2021 | -82.84M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Beam Therapeutics, Inc. | -359.38M |
| Rallybio Corp. | 26.71M |
| Q32 Bio, Inc. | -19.83M |
| Arrowhead Pharmaceuticals, Inc. | -59.06M |
| Oncolytics Biotech, Inc. | -26.52M |